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It has been well established that HIV-1 entry into the
target cell involves formation of a trimolecular complex
consisting of HIV-1 gp120 envelope, a CD4 receptor, and
a chemokine receptor. Although the sequence of events
leading to the formation of this complex is not fully
understood, it has been proposed that binding of gp120
to CD4 induces conformational changes in both of these
interacting molecules.
CD4 is a membrane glycoprotein that has an important
role in the activation of peripheral T cells and differenti-
ation of thymocytes. CD4 closely associates with TCR
and acts as a signal transducer during T cell activation.
Transmission of CD4-induced signaling occurs through
activation of tyrosine kinase Lck, a T cell-specific protein
kinase (PTK) which associates with the cytoplasmic tail
of the CD4 receptor. Activation of Lck is essential for the
signaling pathway that controls the activation and prolif-
eration of thymocytes. However, in addition to its role as
a tyrosine kinase, Lck can act as an adaptor protein by
providing a docking site for the recruitment of down-
stream signaling molecules. In fact, Lck has the potential
to interact through its SH2 and SH3 domains with various
target proteins.
The signaling properties of the CD4 receptor seem to
be dispensable for HIV-1 entry; however, binding of HIV-1
virions or gp120 glycoprotein to CD4 receptors triggers a
broad spectrum of signaling pathways that can modulate
the activation status of the cells and/or affect the posten-
try stages of HIV-1 replication. Thus, cells expressing the
truncated form of CD4, which does not associate with
Lck, show delayed HIV-1 replication and consequently
delayed cell death by apoptosis (Guillerm et al., 1998).
The mechanism by which Lck generates intracellular
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signals upon HIV-1 binding and the intermediates in the
CD4-mediated signaling cascade have not yet been
clearly characterized. It was shown that HIV-1 binding
stimulates both phosphatidylinositol-3-kinase (PI3-K) and
PI4-K (Prasad et al., 1993; Schmid-Antomarchi et al.,
1996); however, only PI3-K was found to interact directly
with Lck. It was also shown that activated Lck directly
associates with and phosphorylates a serine/threonine
kinase Raf-1. This Ras-independent Lck/Raf-1 signaling
pathway (Popik and Pitha, 1996) feeds into a classical
MAPK ERK pathway. Thus, HIV-1 binding to CD4 induces
phosphorylation of MAPK ERK, activation of transcription
factors NFkB and AP-1, and consequently expression of
cytokine and chemokine genes (Briant et al., 1998; Popik
and Pitha 1996; Popik et al., 1998).
The outcome of the T cell signaling induced by HIV-1
binding to CD4 can be modulated by the signals elicited
by concomitant engagement of other membrane recep-
tors. Thus, crosslinking of CD4 receptors, which tran-
siently stimulates ERK activity, can interfere with the
subsequent TCR/CD3-mediated activation of CD41 T
cells by suppressing CD3-induced activation of ERK
(Chirmule et al., 1999). These observations indicate that
binding of HIV-1 virions to CD4 receptors results in par-
tial activation of T cells and alters their ability to respond
to signaling mediated through TCR. Since HIV-1 gp120
interacts also with chemokine receptors and proteogly-
cans, it is likely that engagement of these molecules may
also modify signaling generated by the gp120–CD4-co-
receptor complex.
The conformational changes induced in the HIV gp120
molecule upon its binding to the CD4 receptor increase
binding affinity of gp120 to the coreceptor (Sattentau et
al., 1993; Trkola et al., 1996). These changes are required
for fusion of HIV with a cellular membrane. In addition,
interaction of gp120 with a chemokine receptor may
result in activation of different cellular signaling path-
ways.
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IREVIEChemokine receptors belong to a family of seven
transmembrane-spanning receptors that signal through
heterotrimeric G proteins composed of a monomeric Ga
and heterodimer Gbg subunits. Upon stimulation with a
pecific ligand, the cytoplasmic regions of the receptor
ndergo conformational changes that allow the receptor
o interact with G proteins. This association causes fur-
her conformational changes in the G proteins that facil-
tate an exchange of Ga subunit-bound GDP with GTP
and leads to dissociation of Ga and Gbg. The activated
G protein subunits then bind to and regulate many dif-
ferent cellular effectors (Hamm, 1998; Gutkind, 1998).
However, significant evidence has accumulated which
shows that G protein-coupled receptors (GPCRs) can
signal not only through interaction with G proteins but
also with other cellular proteins (Hall et al., 1999).
A spectrum of chemokine receptors that may serve as
HIV-1 entry cofactors has been identified. However, a
large body of evidence suggests that two of the recep-
tors, CCR5 and CXCR4, play a dominant role in the HIV-1
entry into primary cells (Zhang et al., 1998). CXCR4 was
originally identified as an orphan chemokine receptor
which is expressed on myeloid cells, neutrophils, and T
lymphocytes and was shown to be a coreceptor for entry
of T cell tropic (X4) HIV-1. It was later recognized that
lymphocyte chemoattractant SDF-1 is a natural ligand for
CXCR4 which can inhibit X4 HIV-1 infection of CD41 T
lymphocytes. CCR5 is expressed in lymphoid organs,
peripheral T lymphocytes, and macrophages (Raport et
al., 1996) and was found to bind a number of chemokines
including MIP-1a, MIP-1b, RANTES, and MCP-2. CCR5
as found to be a major coreceptor for entry of macro-
hage tropic (R5) HIV-1. Accordingly, MIP-1a, MIP-1b,
and RANTES are effective inhibitors of HIV-1 infection.
Despite numerous studies that address the role of
CXCR4 and CCR5 in HIV-1 infection, relatively little is
known about the signaling pathways mediated by these
receptors. It was shown that binding of a chemokine
DF-1 to its cognate receptor CXCR4 resulted in phos-
horylation of focal adhesion components, including the
elated adhesion focal tyrosine kinase RAFTK/Pyk2, Crk,
nd the cytoskeleton protein paxilin (Ganju et al., 1998).
hosphorylation of RAFTK/Pyk2 could also be induced
y binding of b chemokines, RANTES and MIP-1b, to the
CCR5 receptor. Interestingly, tyrosine phosphorylation of
Pyk2 was also triggered by gp120 derived from X4 and
R5 HIV-1 strains (Davis et al., 1997), suggesting that
binding of the HIV-1 envelope to CXCR4 and CCR5 may
generate signaling pathway(s) similar to those initiated
by binding of the natural ligands to these receptors.
Similarly, phosphorylation of paxilin was not limited to
signaling through the CXCR4 receptor but could also be
induced by binding of RANTES and MIP-1b to the CCR5
eceptor.
2 MINPhosphorylation of the focal adhesion components
AFTK/Pyk2, paxilin, and Crk and their association withach other may result in the formation of signaling com-
lexes that have a potential to reorganize actin cytoskel-
tal structures. Consequently, this event may affect cell
otility and cell polarization. Interestingly, changes in the
ctivation of focal adhesion complexes induced by che-
okines a and b can be elicited by both T-tropic and
macrophage-tropic HIV-1. This observation suggests that
some signaling responses induced by HIV-1 binding to
chemokine coreceptors may be independent of cellular
tropism of the virus. However, some of these responses
may also be generated by engagement of the CD4 re-
ceptor alone (Cicala et al., 1999).
Recently, new signaling intermediates activated by
binding of MIP-1b to CCR5 were described (Ganju et al.,
2000). These included the SH2 domain-containing cyto-
plasmic tyrosine phosphatases SHP1 and SHP2 as well
as Src-related kinase Syk. Association of SHP1 with
RAFTK, Syk, and Grb2 resulted in formation of a multi-
component signaling complex. While SHP-1 negatively
regulated a number of signaling pathways by dephos-
phorylation of specific tyrosine residues on proteins,
SHP2 functioned as a positive regulator. Whether a sim-
ilar signaling pathway is also induced upon binding of
the HIV-1 envelope to the CCR5 receptor remains un-
known.
Studies with the chemokine receptor chimeras sug-
gested the existence of multiple receptor domains im-
portant for HIV-1 entry that can be separated from the
domains that regulate chemokine-mediated signaling re-
sponses. However, there are also common structural
determinants required for chemokine receptor-mediated
signaling and HIV-1 coreceptor activity (Alkhatib et al.,
1997). This suggests that chemokines and HIV-1 gp120
may initiate both common and unique, ligand-specific
signaling. Indeed, signals induced by binding of chemo-
kines to the receptors do not always mimic the interac-
tion of the HIV-1 envelope with the chemokine receptors.
Thus, binding of SDF-1 to CXCR4 was shown to stimulate
the MAPK ERK pathway in CD41 T cells; however, inter-
action of X4 HIV-1 with the chemokine receptor did not
activate this pathway (Popik et al., 1998). In contrast,
viruses using CCR5 for entry efficiently activated ERK as
well as JNK and p38 MAP kinases (Popik and Pitha,
1998). Similarly, the ionic signaling response induced by
the interaction of HIV-1 gp120 with CCR5 or CXCR4 in
primary macrophages and the signaling response in-
duced by the interaction of the receptors with their spe-
cific ligands MIP-1b and SDF-1a were not identical (Liu
t al., 2000). Surprisingly, neither SDF-1a nor MIP-1b
activated nonselective cation channels that were opened
by R5 and X4 HIV-1 gp120. These results suggest that
signaling generated by gp120 does not merely reflect
signaling induced by chemokines but, in some in-
stances, represents a unique signaling pathway that may
Wcontribute to pathogenesis of HIV-1.










to CXCmembranes has been recently shown (Xiao et al., 1999).
This association seems to be required for HIV-1 infection
since inhibition of the CD4–CCR5 interaction inhibited R5
HIV-1 envelope-mediated fusion and HIV-1 entry. In con-
trast, association between CD4 and CXCR4 was negligi-
ble, but was substantially increased upon binding of
gp120. It is therefore tempting to speculate that binding
of the R5 HIV-1 envelope to CD4–CCR5 complexes may
initiate a signaling pattern distinct from that induced by
either receptor alone or by binding of the X4 HIV-1 en-
velope (Fig. 1).
HIV-1 entry into target cell is a multistep process that
requires interactions between the viral envelope glyco-
proteins and cellular CD4 and chemokine receptors. An
accumulating body of evidence suggests that other cell
surface molecules, either independently or in associa-
tion with CD4 and chemokine receptors, may participate
in virus binding and entry. Consequently, these additional
FIG. 1. Interaction of R5 and X4 HIV-1 gp120 with different cell surfac
gp120 binds to the preassembled CD4–CCR5 complex. This interaction
(Signal 1 & 2). In contrast, X4 HIV-1 gp120 binds first to CD4 and then t
may interfere with the association between the CD4–gp120 complex
generated mostly by the CD4 receptor (Signal 1). Subsequent binding
may contribute differently to HIV pathogenesis.
MINinteractions between the viral envelope glycoprotein and
the proteins at the surface of the plasma membrane may
l
tmodulate CD4- and/or chemokine receptor-mediated
signaling. It was shown that in addition to viral proteins,
plasma membrane glycoproteins can be selectively in-
corporated into HIV-1 virions during budding from a
plasma membrane. These include HLA class I and II
antigens (Rossio et al., 1995), adhesion molecules LFA-1
and ICAM (Orentas and Hildreth, 1993; Fortin et al., 1997),
as well as other cell-type-specific antigens (Lawn et al.,
000). Interaction of these virus-acquired membrane gly-
oproteins with their respective cellular counterparts
ay generate signaling that will result in a change in the
ctivation status of the cell (Ni et al., 1999). However,
hile it has been shown that the interaction between the
irion-bound adhesion molecule and its cellular counter-
art potentiates HIV-1 infectivity (Fortin et al., 2000), the
ole of signaling induced in this process remains un-
nown.
The interactions between virion-incorporated and cel-
ules may result in stimulation of distinct signaling pathways. R5 HIV-1
sult in simultaneous stimulation of CD4- and CCR5-mediated signaling
XCR4 receptor. Interaction of the X4 gp120 V3 loop with cellular HSPG
CR4. Consequently, the earliest X4 gp120-induced signaling may be





IREVIEular surface adhesion molecules occur independently of





























IREVIEthe HIV-1 envelope can interact not only with CD4 and
chemokine receptors but also with cell surface heparan
sulfate proteoglycans (HSPGs). This interaction involves
the V3 loop of gp120 (Roderiquez et al., 1995; Moulard et
l., 2000) as well as the newly characterized conserved
oreceptor binding surface on gp120 (Moulard et al.,
000).
The heparin-like moieties of HSPG bind and modulate
he activities of several matrix components, growth fac-
ors, proteinase inhibitors, and cell–matrix adhesion mol-
cules (Hileman et al., 1998). Substantial evidence sug-
gests that cell surface-associated HSPGs act as “core-
ceptors” for FGF, EGF, Wnt, and members of the TGF-b
superfamily and facilitate the interactions of these li-
gands with the specific receptors. Thus, HSPGs potenti-
ate the activity of these signal-transducing receptors.
Whether HSPG plays a role in HIV-1-mediated cellular
signaling is unknown. It has been shown that dextran
sulfate can interfere with the association between X4
HIV-1 gp120 and CXCR4, while it does not have any
detectable effect on the gp120–CD4 interaction (Moulard
et al., 2000). In contrast, the interaction between poly-
nions and R5 HIV-1 gp120 was weak or undetectable.
hese results, together with the earlier observations that
howed constitutive association between CD4 and CCR5
nd only a marginal association, if any, between CD4 and
XCR4 (Xiao et al., 1999), suggest that signaling induced
immediately upon binding of X4 HIV-1 may be generated
primarily by the X4 gp120–CD4 interaction. In contrast,
binding of R5 HIV-1 gp120 may trigger signaling through
both CD4 and CCR5 receptors. It is tempting to speculate
that selective interactions of gp120 with cellular proteo-
glycans may result, at least partially, in a differential
signaling outcome induced by X4 versus R5 HIV-1. How-
ever, the implications of gp120 binding to HSPG in the
outcome of HIV-1 signaling are unclear, since the prin-
cipal target cells for HIV-1 infection in vivo, CD41 T cells
nd macrophages, express rather low levels of HSPG on
ell membranes compared to endothelial and epithelial
ells. It may, however, facilitate the transfer of HIV-1
cross the brain–endothelial cell barrier.
The biological activities of chemokines seem to be
ffected by their association with cellular or extracellular
atrix glycosaminoglycans (GAGs). Although the biolog-
cal role of chemokine–GAG complexes in vivo is un-
lear, many results suggest that GAGs immobilize and
ocally concentrate the chemokines. This may promote
heir oligomerization and facilitate their presentation to
he receptors. In this respect, it has recently been dem-
nstrated that chemokines SDF-1a (Mbemba et al., 1999;
Amara et al., 1999) and RANTES (Trkola et al., 1999) are
able to interact with glycosaminoglycans as well as with
CD4 and chemokine receptors.
The activation of signal transduction pathways by
4 MINbinding of HIV-1 gp120 to CD4 and chemokine receptors
raises the question of whether the modulation of cellular
o
asignaling contributes to HIV pathogenesis. Chronic acti-
vation of the immune system is commonly observed in
AIDS, and aberrant expression of inflammatory cytokines
observed during progression of the disease has been
implicated in the pathogenicity of HIV-1.
It has been shown that binding of both X4 and R5 HIV-1
virions or corresponding envelopes to the CD4 receptor
initiated signaling pathways independent of the binding
to chemokine receptors and resulted in an expression of
cytokine and chemokine genes (Popik et al., 1998; Popik
and Pitha, 1998). Aberrant expression of inflammatory
genes in vivo may contribute significantly to HIV-1 repli-
cation as well as to deregulation of the immune system.
Furthermore, crosslinking of CD4 receptors by the HIV-1
envelope may lead to partial T cell activation and inter-
ference with the signals mediated by the TCR/CD3 com-
plex and result in functional unresponsiveness resem-
bling T cell anergy.
Progressive depletion of CD41 T cells is a hallmark of
HIV-1 disease. Destruction of these cells may involve
apoptosis. It was shown that this process could be in-
duced as a result of binding of gp120 to CD4 (Moutouh et
al., 1998; Guillerm et al., 1998). Activation of Lck seems
not to be required for the induction of apoptosis since
cells expressing the mutated CD4 receptor unable to
associate with Lck also undergo apoptosis. However, the
role played by the cytoplasmic tail of CD4 in the induc-
tion of apoptosis remains obscure.
GPCRs are also able to transmit proapoptotic or anti-
apoptotic signaling and utilization of CXCR4 by HIV-1
was shown to be sufficient to trigger CD41 T cell deple-
tion (Penn et al., 1999; Schramm et al., 2000). Also,
neuronal apoptosis induced by HIV-1 gp120 and SDF-1
was shown to be mediated by the CXCR4 receptor (Hes-
selgesser et al., 1998). However, the role of signaling in
these processes was not addressed.
The nature of chemokine receptor-mediated signaling
in apoptosis is poorly understood. While SDF-1 shows
proapoptotic activity in neuronal cells, in T lymphocytes
SDF-1 activates PI 3-kinase and Akt/protein kinase B
which are both implicated in antiapoptotic pathways
(Sotsios et al., 1999). Involvement of the caspase-depen-
dent apoptotic signaling pathway induced by the en-
gagement of CXCR4 by gp120 was recently suggested
(Biard-Piechaczyk et al., 2000). However, this process did
not involve activation of the Gi protein which couples to
and transduces “classical” chemokine receptor-depen-
dent signaling (Berndt et al., 1998; Biard-Piechaczyk et
l., 2000).
The ability of X4 HIV-1 gp120 to transduce proapo-
totic, Gi-independent signaling may result from the in-
bility of the X4 envelope to generate CXCR4-dependent
ntiapoptotic signaling rather than from intrinsic proper-
ies of the chemokine receptor. Accordingly, stimulation
Wf the MAP kinase MEK/ERK pathway, often involved in



































IREVIEviruses using CCR5 but not CXCR4 receptors (Popik and
Pitha, 1998; Popik et al., 1998).
The effect of chemokine receptor-mediated signaling
on HIV-1 infection is unclear. However, the observation
that b-chemokines MIP-1a, MIP-1b, and RANTES, which
inhibit entry and replication of macrophage-tropic R5
HIV-1, increased replication of T-tropic X4 HIV-1 strains in
primary CD41 T cells (Kinter et al., 1998) suggests that
the signaling triggered by the engaged chemokine re-
ceptor can stimulate HIV-1 replication. Interestingly, the
observed CCR5-mediated enhancement of X4 HIV-1 rep-
lication was associated with increased colocalization of
CD4 and CXCR4 receptors (Kinter et al., 1998). These
results further suggest that colocalization of CD4 and
CXCR4 receptors enhances X4 HIV-1 infection (Dimitrov
et al., 1999). Further experiments are required to dissect
the signaling components involved in this process.
The effect of chemokine receptor signaling on HIV-1
infection was recently substantiated by the finding of a
strong correlation between the levels of calcium mobili-
zation induced in macrophages by the engagement of
CCR5 by HIV-1 and replication of HIV-1 in these cells
(Arthos et al., 2000). Involvement of CCR5-mediated sig-
naling was further confirmed by the observation that
replication of the R5 HIV-1 primary isolate unable to
replicate in macrophages could be promoted by signal-
ing induced by binding of MIP-1a to CCR5. Similarly,
nefficient replication of the primary CXCR4 isolate in
acrophages was significantly increased by MIP-1b.
The requirement for activation of the MAP kinase
MEK/ERK pathway in the replication of R5 and X4 HIV-1
strains in quiescent primary CD41 T lymphocytes was
ecently documented (Popik and Pitha, 2000). In the pres-
nce of the MEK/ERK pathway inhibitor, replication of X4
ut not R5 HIV-1 was significantly inhibited at the level of
uclear localization of the proviral DNA. These results,
ogether with the earlier observations that R5 but not X4
IV-1 efficiently activated MEK/ERK as well as JNK and
38 MAP kinases (Popik and Pitha, 1998), suggest that
5 viruses may replicate preferentially in suboptimally
ctivated primary CD41 T cells. This characteristic of R5
iruses may be one of the factors that gives a replicative
dvantage to macrophage-tropic over T-tropic HIV-1 iso-
ates during the early stages of infection (Vicenzi et al.,
999).
These data indicate that selection of CD4 and chemo-
ine receptors by HIV-1 was not a random choice but that
he HIV-1 virus has been using these receptors to induce
ignaling that facilitate the early stages of its own repli-
ation cycle. The activation of signaling pathways alters
he activation status of the host T cells and possibly
acrophages as well and results in functional modifica-
ion of responsiveness to natural stimuli. Thus, under-
MINtanding of the signaling induced by the engagement of
hese receptors upon HIV-1 binding could potentiallyffer new strategies for the interference with HIV-1 rep-
ication and virus-mediated immune pathogenicity.
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